In the final segment, CEO Bram Goorden covers IXICO PLC (LSE:IXI, OTC:PHYOF)’s strong order book, revenue visibility, and growing pipeline of Alzheimer’s projects. Learn why the company sees significant opportunities for partnerships and expansion into new verticals.
Click the link in the video, or visit the IXICO profile to view the full interview.
#Neuroscience #CNS #Biomarkers #ClinicalResearch #LifeSciences #IXICO #Neuroimaging #AlzheimersResearch #ParkinsonsDisease #AIDrivenHealthcare #Biomarkers #ClinicalResearch #HealthcareInnovation #UKStocks #BramGoorden #ProactiveInvestors #MedicalAI #LifeSciences #PostMarketingSurveillance #AI #AIinHealthcare #Alzheimers #Parkinsons #BiotechInnovation